Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 437

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 437
---
 Data: |   |        As of 
 December 31, 
         2024 |   |     |   |        As of 
 December 31, 
         2023 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:---------------------------------|:--|-------------:|:--|:----|:--|-------------:|:--|
| Total current assets                                                                                                                                                                  |                                  | $ |       16,868 |   |     | $ |      209,440 |   |
| Cash and Investments held in trust                                                                                                                                                    |                                  |   |    9,021,005 |   |     |   |   50,477,963 |   |
| Total assets                                                                                                                                                                          |                                  |   |    9,037,873 |   |     |   |   50,687,403 |   |
| Total liabilities                                                                                                                                                                     |                                  |   |   10,434,584 |   |     |   |    8,491,480 |   |
| Class A ordinary shares subject to possible redemption 751,837 and 4,537,829 shares at redemption value of $12.00 and $11.12 per share as of December 31, 2024 and 2023, respectively |                                  |   |    9,021,005 |   |     |   |   50,477,963 |   |
| Total shareholders’ deficit                                                                                                                                                           |                                  |   |  (10,417,716 | ) |     |   |   (8,282,040 | ) |

265

SELECTED HISTORICAL FINANCIAL INFORMATION OF SEMNUR The following selected statements of operations data for the years ended December 31, 2024 and 2023 and the selected balance sheet data as of December 31, 2024 and 2023 have been derived from Semnur’s audited financial statements included elsewhere in this proxy statement/prospectus. The historical results presented below are not necessarily indicative of the results to be expected for any future period. You should read the following selected financial information presented below in conjunction with the section of this proxy statement/prospectus titled “ Management’s Discussion and Analysis of Financial Condition and Results of Operations of Semnur” and Semnur’s audited and unaudited financial statements and the related notes included elsewhere in this proxy statement/prospectus.

|                                                                         |     | Year Ended December 31, 
 2024                    |             |